Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer
Emily E. Bosco(Early Intervention Foundation), David A. Tice(Unknown)
Cited by 17
Related Papers
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
|Journal of Clinical Investigation|2006|192
Patient-derived xenograft (PDX) tumors increase growth rate with time
|Oncotarget|2016|80
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
|Journal of Clinical Investigation|2023|49